🇺🇸 Interleukin 2 in United States

408 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 70 reports (17.16%)
  2. Pyrexia — 65 reports (15.93%)
  3. Hypotension — 44 reports (10.78%)
  4. Pain — 40 reports (9.8%)
  5. Disease Progression — 37 reports (9.07%)
  6. Nausea — 36 reports (8.82%)
  7. Fatigue — 33 reports (8.09%)
  8. Diarrhoea — 30 reports (7.35%)
  9. Cardiotoxicity — 27 reports (6.62%)
  10. Chills — 26 reports (6.37%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Interleukin 2 approved in United States?

Interleukin 2 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Interleukin 2 in United States?

Assistance Publique - Hôpitaux de Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.